InvestorsHub Logo
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: tilator post# 30947

Thursday, 10/26/2017 4:55:52 PM

Thursday, October 26, 2017 4:55:52 PM

Post# of 38634
I thought we're talking about why IPCI couldn't get a partner for Glucophage and how difficult it is to market a new product as well as all the competitions out there?

Warehouse managers are well aware of stock rotations and demand. They stock enough quantity to satisfy the demand, and not keeping too big an inventory. That's something else the retail sellers have to worry about. What does this have anything to do with IPCI getting a partner?

When they run low on inventory, they will of course think about where they get more supply. So what are you saying?

When they buy, they are going to look at price of course, and it's no brainer you won't want to buy supplies that has shorter expiration date if you can't rotate out your inventory fast enough.

Frankly with that many manufacturers, they have a lot of choices where to buy and how quickly and reliably they can get the supply they asked for. Doesn't take much to see there are a lot of manufacturers already and drugs aren't something you can manufacture and stock pile big supply only to expire and become worthless.

That's making it tough for IPCI to get a partner simply because there are too much competition and whole lot of supply out in the market.